Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: A systematic review and meta-analysis

March 15, 2018

Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: A systematic review and meta-analysis

Published on 03/14/2018

previous post: Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): An open-label, single-arm, phase 2 study
next post: Audiologic natural history of small volume cochleovestibular schwannomas in neurofibromatosis type 2